Medical School
Istanbul University Faculty of Medicine, 1994
Post-Graduate Training
Trakya University Faculty of Medicine, Department of Obstetrics and Gynecology, Edirne, 2000
Istanbul University Istanbul Faculty of Medicine, Research Assistant, 1988-1994
Trakya University Faculty of Medicine, Specialist Doctor, 1994-2000
Trakya University Faculty of Medicine, Assistant Professor, 2000-2003
Trakya University Faculty of Medicine, Associate Professor, 2003-2006
Trakya University Faculty of Medicine, Professor, 2006-2011
Trakya University Faculty of Medicine, Professor, 2011-2013
Istanbul Kemerburgaz University Faculty of Medicine, 2013-2014
Professional Experience
Trakya University Faculty of Medicine, 1994-2011
Reyap Healthcare Group, 2011-2012
Medicalpark Bahcelievler Hospital, Kemerburgaz University Hospital, 2012-2013
Reyap Healthcare Group, Corlu and Istanbul, 2013-2020
Beykent University Hospital, 2020-2021
Medicana International Istanbul Hospital, 2021-Present
Medical Interest
Obstetrics and Gynecology
Expertise in Gynecological Oncology Surgery
Experience and Instructor in Urogynecology and Pelvic Floor Disorders
Special Experience
Obstetrics and Gynecology
Expertise in Gynecological Oncology Surgery
Experience and Instructor in Urogynecology and Pelvic Floor Disorders
Scientific Publications
A. International Publications
A-3. Authorship of Articles and Reviews published in peer-reviewed journals scanned by Science Citation Index (SCI), SCI-Expanded, Social Science Citation Index (SSCI) and Art And Huminities Citation Index (AHCI):
A-3.1. F Güçer, P Balkanlı Kaplan, M Yüksel, MA Yüce, M Türe, T Yardım. “Maternal serum Tumor necrosis factor-α in patients with preterm labor”, J Reprod Med, 46(3): 232-236 (2001).
A-3.2. F Gücer, P Balkanlı-Kaplan, L Doğanay, MA Yüce, E Demiralay, NC Sayın , T Yardım. “The effect of paclitaxel on primordial follicular reserve in mice”, Fertil Steril, 76: 628-629 (2001).
A-3.3. F Varol,A Saltık, P Balkanlı Kaplan, T Kılıç, T Yardım. “Evaluation of gestational age based on ultrasound fetal growth measurements”, Yonsei Med J, 42 (3): 299-303 (2001).
A-3.4. F Gücer, P Balkanlı-Kaplan, M Yüksel, NC Sayın, MA Yüce, T Yardım. “Maternal serum levels of tumor necrosis factor-α and interleukin-2 receptor in threatened abortion: a comparison with normal and pathologic pregnancies”, Fertil Steril, 76: 707-711 (2001).
A-3.5. P Balkanlı-Kaplan, F Gücer, NC Sayın, MA Yüce, T Yardım. “Effects of oral continuous and transdermal cyclic 17-β estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women”, J Reprod Med, 47: 651-655 (2002).
A-3.6. P Balkanlı-Kaplan, F Gücer, NC Sayın, M Yüksel, MA Yüce, T Yardım. “Maternal serum cytokine levels in women with hyperemesis gravidarum in the first trimester of pregnancy”, Fertil Steril, 79: 498-502 (2003).
A-3.7. NC Sayın, F Gücer, P Balkanlı-Kaplan, MA Yüce, S Ciftci, M Kücük, T Yardım. “Elevated serum TNF-α levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome”, J Reprod Med, 48: 165-170 (2003).
A-3.8. NC Sayın, F Gücer, P Balkanlı-Kaplan, MA Yüce, T Yardım. “Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with polycstic ovary syndrome”, Gynecol Endocrinol 17: 387-396 (2003).
A-3.9. NC Sayın, FG Varol, P Balkanlı-Kaplan, M Sayın. “Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor”, J Perinat Med, 32: 220-224 (2004).
A-3.10. MA Yüce, P Balkanlı-Kaplan, F Güçer, L Doğanay, S Altaner, T Canda, T Yardım. “Prevention of cyclophosphamid-induced ovarian damage by concomitant administration of GnRHa in mice: A dose-dependent relationship? ”, Eur J Gynecol Oncol, 25: 628-631 (2004).
A-3.11. F Güçer, K Tamussino, F Kıel, P Balkanlı-Kaplan, MA Yüce, “Thrombocytosis in gynecologic malignancies”, Anticancer Res, 24: 2053-60 (2004).
A-3.12. MD Barber, AMC Ashby, CCG Chen, P Kaplan, MF Paraiso, MA Walters. “Perioperative complications and adverse events of the Monarc trans-obtrator tape compared to the tension free vaginal tape”. Am J Obstet Gynecol;195: 1820-5 (2006).
A-3.13. NC Sayın, FG Varol, MA Yüce, P Balkanlı Kaplan, N Ahmet, N Süt, F Güçer. “Do routine preoperative imaging techniques facilitate the operation in endometrial cancer?” Arch Gynecol Obstet; 27: (2008).
A-3.14. HA Inal, P Balkanlı Kaplan, U. Usta, E. Taştekin, A. Aybatlı, B. Tokuc. “Neuromuscular morphometry of the vaginal wall in women with anterior vaginal wall prolapse”. Neurourol Urodyn 29: 458-63 (2010).
A-3.15. P Balkanlı Kaplan, U Usta, HA İnal, E Taştekin, B Tokuç. “Neuromuscular morphometry of the uterine ligaments and vaginal wall in women with pelvic organ prolapse”. Neurourol Urodynamics 30: 126-32 (2011).
A-3.16. Aybatlı, A., P Balkanlı-Kaplan, M Alicik, NC Sayın, MA Yüce, “Single dose methotrexate in treatment of ectopic pregnancy:A review of 32 case”, Balkan Med J.,28:10-13, (2011).
A-3.17. H Kahyaoğlu Süt, P Balkanlı Kaplan, N Süt, S Tekbaş. “The assessment of quality of life in female Turkish patients with overactive bladder”. Int J Nursing Pract, 18: 20-27, (2011).
A-3.18. P Balkanlı Kaplan, N Süt, H Kahyaoğlu Süt. “Validation, cultural adaptation and responsiveness of two pelvic floor specific quality of life questionnaire PFDI-20 and PFIQ-7 in a Turkish population. Eu J Gyn Obstet Rep Biol; 2012 Jun;162(2):229-33 (Yayına kabul) 2011.
A-4. Science Citation Index (SCI), SCI-Expanded, Social Science Citation Index (SSCI) ve Art And Huminities Citation Index (AHCI) tarafından taranan hakemli dergilerde yayımlanmış Vaka Takdimi ve Teknik Not Yazarlığı:
A-4.1. F Güçer, F Özyılmaz, P Balkanlı-Kaplan, N Mülayım, Ö Aydın. “Ovarian hemangioma presenting with hyperandrogenism and endometrial cancer: a case report”, Gynecol Oncol, 94: 821-824 (2004).
A-4.2. F Güçer, Ö Yılmaz, P Balkanlı-Kaplan, MA Yüce, “Complete remission of an endometrial carcinoma with bilateral multiple pulmonary and extrapelvic metastases treated by surgery and chemotherapy consisting of paclitaxel and carboplatin”, Int J Gynecol Cancer, 15: 1160-1162 (2005).
A-4.3. F Güçer, F Öz-Puyan, Ö Yılmaz, N Mülayım, P Balkanlı-Kaplan, MA Yüce. “Endometrial carcinoma with laparotomy wound recurrence: complete remission following surgery and chemotherapy consisting of paclitaxel and carboplatin”, Int J Gynecol Cancer, 15: 1195-1198 (2005).
A-4.4. P Balkanlı-Kaplan, F Güçer, F Öz-Puyan, MA Yüce, K Kutlu. “Placenta percreta diagnosed following a first trimester pregnancy termination: A case report”, J Reprod Med, 51 (8): 662-4 (2006).
A-4.5. MA Yüce, A Aybatlı, P Balkanlı Kaplan. “Delayed interval delivery of an in-vitrofertilized triplet pregnancy with premature rupture of membranes in the second trimester”. Arch Gynecol Obstet ; 281:269-72 (2010).
A-5. Letter to the Editor published in peer-reviewed journals indexed by Science Citation Index (SCI), SCI-Expanded, Social Science Citation Index (SSCI), and Art and Humanities Citation Index (AHCI):
A-5.1. P Balkanlı-Kaplan, F Güçer, MA Yüce. “T-helper 2-cytokine levels in women with threatened abortion”, Eur J Obstet Gynecol Reprod Biol, 114: 239-240 (2004).
A-7.a. Case reports and technical notes published or accepted for publication in peer-reviewed international journals that have been regularly published at least twice a year for the past 5 years and indexed by international editorial boards, at least half of which consist of international editors, excluding those indexed by Science Citation Index (SCI), SCI-Expanded, Social Science Citation Index (SSCI), and Art and Humanities Citation Index (AHCI).
A-7.a.1. MA Yüce, F Güçer, P Balkanli-Kaplan, NC Sayın. “Medical management of ectopic pregnancy with extremely high β-HCG levels: a case report”, Clin Exp Obstet Gynecol, 3: 242-243 (2004).
A-7.a.2. A Aybatlı, P Balkanlı Kaplan, MA Yüce, Ö Yalçın. “Huge solitary pelvic hidatid cyst presenting as an ovarian malignancy: case report”. J Turkısh-German Gyn Assoc.; 10(3): 181-3 (2010).
A-7.a.3. A Aybatlı, C Sayın, P Balkanlı Kaplan, F Varol, N Süt. “Evaluation of tumor angiogenesis with HIF-1alpha and microvessel density in patients with endometrial cancer. J Turkish-German Gyn Assoc. (TJGGA-35467, In Press).
A-12. At a peer-reviewed congress or symposium periodically organized by an internationally renowned society or organization;
A-12.b- Authorship of oral papers with submitted and published abstracts:
A-12.b.1. E Tasalı, Ö Acicbe, E Büyükateş, P Balkanlı, Z Yüce, T Altuğ, S Büyükdevrim. “The effects of ultraviolet light on tumor growth and survival in Ehrlich ascites tumor inoculated mice”, 6th International Medical Sciences Student Congress, İstanbul, 16-18 Mayıs 1990.
A-12.b.2. N Cabioğlu, P Balkanlı, Ö Acicbe, MA Talay, A Turna, T Altuğ, S Büyükdevrim. “The effect of lactation on ehrlich ascites tumor growth in mice”, 7th International Medical Sciences Student Congress, İstanbul, 23-25 Mayıs 1991.
A-12.b.3. F Varol, A Saltık, P Kaplan, T Kılıç, T Yardım. “Evaluation of gestational age and birth weight based on ultrasound fetal growth measurements: A report of 627 cases from Edirne/Turkey”, XVI FIGO World Congress of Gynecology and Obstetrics, Washington D.C., USA, 3-8 September 2000.
A-12.b.4. F Gücer, P Balkanlı-Kaplan, M Yüksel, NC Sayın, MA Yüce, T Yardım. “Serum spiegel der abortus-induzierenden zytokine in abortus imminens”, Gemeinsame Jahrestagung der Bayerischen und der Österreichischen Gesellschaften für Gynakologie und Geburtshilfe. Baden bei Wien, 13-16 June 2001.
A-12.b.5. Canda, M.T., H.A. Bağrıyanık, P.B. Kaplan, O. Yılmaz, F. Güçer, M.A. Yüce ve K. Tugyan. “Effects of co-administration of raloxifene on long-term gonadotrophine releasing hormone agonist treated rat endometrium”, VI. International Congress of the Turkish-German Gynecological Association. Antalya, 18-22 May 2005.
A-12.b.6. MD Barber, AM Gostilo-Ashby, CCG Chen, P Kaplan, MF Paraiso, MD Walters. “Perioperative complications and adverse events of the Monarc transobturator tape compared to the tension-free vaginal tape”, Thirty-second Annual Meeting of Gynecologic Surgeons Meeting’ Tucson, Arizona, USA, 3-5 Nisan 2006.
A-12.b.7. A Aybatlı, P Balkanlı Kaplan, N Süt, MA Yüce, NC Sayın, F Varol. “Human chorionic gonadotropin AUC as a new parameter to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy”. 14th World Congress of Gynecological Endocrinology, Firenze, Italia, 4-7 March 2010.
A-12.d- Tam metni veya özeti yayınlanan poster bildiri yazarlığı:
A-12.d.1. NC Sayın, F Gücer, MA Yüce, P Balkanlı-Kaplan, L Ozgen, T Yardım. “Insulin resistance and lipid profiles in women with PCO”, 18th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE). Vienna, Austria, Abstract P179; Hum Reprod, 17 (Abstract Book 1): P530, 1-3 July 2002.
A-12.d.2. NC Sayın, F Varol, P Balkanlı-Kaplan, T Canda. “Maintenance therapy with oral nifedipine after intravenous ritodrine and verapamil”, 7th Turkish Hellenic Scientific Meeting on Maternal Fetal Medicine & Perinatology. İstanbul, 19-20 April 2002.
A-12.d.3. L Ozgen, NC Sayın, P Balkanlı-Kaplan, F Varol “Pregnancy with Type I osteogenesis imperfecta: a case report”, 7th Turkish Hellenic Scientific Meeting on Maternal Fetal Medicine & Perinatology. İstanbul, 19-20 April 2002.
A-12.d.4. MA Yüce, PB Kaplan, L Candan, F Güçer, T Canda, T Yardım. “Prevention of cyclophosphamide-induced menopause by concomitant administration of GnRHa: A dose dependent relationship? ”, 2nd International and 5th National congress on Menopause & Osteoporosis, İstanbul, 18-21 September 2002.
A-12.d.5. P Balkanlı-Kaplan, HA Bağrıyanık, T Canda, F Güçer, O Yılmaz, A Yüce, T Yardım. “Preventive effects of add-back therapy with raloxifene on tibia histomorphometry in rats administered a long-acting gonadotropin-releasing hormone agonist”, 2nd European Consensus Conference on Menopause. Athens, Greece, 1-4 May 2003.
A-12.d.6. P Balkanlı-Kaplan, F Guger, G Ozden, MA Yüce. “Determining the reasons for admission and information about HRT in women who applied to the menopause outpatient clinic for the first time”, 6th National and 3rd International Menopause and Osteoporosis Congress, Antalya, 19-23 May 2004.
A-12.d.7. P Balkanlı-Kaplan, G Özden, B Tokuç, MA Yüce. “HRT use in postmenopausal women and the effects of reproductive factors on BMD”, IV. International Reproductive Health and Family Planning Congress. Ankara, 20-23 April 2005.
A-12.d.8. B Tokuç, P Balkanlı-Kaplan, G Özden, H Gül. “T.U.T.F. Quality of life in women who applied to the menopause outpatient clinic of the hospital", IV. International Reproductive Health and Family Planning Congress. Ankara, 20-23 April 2005.
A-12.d.9. P Balkanlı-Kaplan, N Tunçbilek, G Özden, Ö Ökten, B Tokuç. “Effects of reproductive factors on mammographic breast density in postmenopausal women”, IV. International Reproductive Health and Family Planning Congress. Ankara, 20-23 April 2005.
A-12.d.10. NC Sayın, FG Varol, A Yüce, P Kaplan, N Ahmet, N Süt, F Güçer. “Routine preoperative computed tomography, intravenous pyelography and rectoscopy do not facilitate the operation in endometrial cancer”. Abstract, S12, Arc Gynecol Obstet 2007; 271 (Suppl1 Abstract Book): Poster-MFM&P-32, Antalya, Turkey, 18-22 May 2007.
A-12.d.11. C İbiş, D Albayrak, H Gençhallaç, O Yalçın, P Balkanlı Kaplan, İ Coşkun. “Giant bilateral late overian metastases of musinous adenocarcinoma of sigmoid colon”. Ist International Interuniversity Gastroenterology Congress, Alexendroupolis, Greece, 29-31 May 2008.
A-12.d.12. MA Yüce, A Aybatlı, P Balkanlı Kaplan. “Delayed delivery of an in vitro fertilized triplet pregnancy with premature rupture of membranes in the second trimester”. XXI. European Congress of Perinatal Medicine, İstanbul, 10-13 Ekim 2008.
A-12.d.13. HA İnal, P Balkanlı Kaplan, U Usta, E Taştekin, A Aybatlı. “Morphometric analysis of the smooth muscle and nerve fibers of the anterior vaginal wall in women with and without pelvic organ prolapse”. International Continence Society 38th Annual Meeting, Kahire, Mısır, 20-24 Ekim 2008.
A-12.d.14. A Aybatlı, P Balkanlı Kaplan, MA Yüce, NC Sayın, FG Varol. “Synchronous tumors of the female genital tract: An analysis 0f 13 cases”. 8th Turkish- German Gynecology Congress, Antalya, Turkey, April 29- 3 May 2009.
A-12.d.15. P Balkanlı Kaplan, A Aybatlı, H Karagöl, N Süt , MA Yüce, F Varol, NC Sayın, N Uzunay, F Güçer. “Ca 125 AUC as a predictor for overian cancer survival”. 16. Meeting of European Society of Gynecologic Oncology (ESGO), Belgrade, Serbia, 11-15 October 2009.
A-12.d.16.NC Sayın, A Aybatlı, PB Kaplan, FG Varol. “Angiomyolipoma of the ovary; report of a case”. 16. Meeting of European Society of Gynecologic Oncology (ESGO), Belgrade, Serbia, 11-15 October 2009.
A-12.d.17. A Aybatlı, NC Sayın, P Balkanlı-Kaplan, FG Varol, Ş.Altaner. “The ınvestıgatıon of tumoral angıogenesıs wıth hypoxıa ınducıble factor-1 A and mıcrovessel densıty ın women wıth endometrıum cancer”, IX.Turkısh-German Gynecology Congress, Antalya, Turkey, 04-08 May 2011.
A-12.d.18. P Balkanlı Kaplan, H Kahyaoğlu Süt, N Süt. “Is clinical diagnosis reliable in assessment of LUTS comparing to the urodynamic studies?”. 41st Annual meeting of the International Continance Society (ICS), Glasgow, Scotland, 28 August- 2 October 2011.
A-12.d.19. FG Varol, N Akış, S Alboy, NC Sayın, P Balkanlı Kaplan. “Plasma Ho-1 and sflt-1 levels of preeclampsia and normal pregnancies”. 4. Congress of the South-east European Society of perinatal Medicine,Belgrad, Sırbistan, 20-22 Mayıs 2011.
A-12.d.20. FG Varol, N Kıyak, NC Sayın, P Balkanlı Kaplan, D Tiyekli. “Angiopoetins in the advanced ovarian cancer”. The 14th World Congress on controversies in Obstetrics & Gynecology COGI, Paris, Fransa, 17-20 Kasım 2011.
B. National Publications
B-3. Published or accepted to be published by national publishers, including the ISBN number, the web address available on the Internet and the address of the publisher.
B-3.a. Chapter authoring in books
B-3.a.1. M Walters, P Balkan Tiger. "Transvaginal Needle Suspensions". Urogynecology and Pelvic Floor Diseases. Haldun G (Eds.), Chapter 20; pages 173-184, Ankara, Güneş Bookstore, 2008.
B-3.a.2. P Balkan Tiger. "Biomaterials and synthetic meshes in pelvic floor reconstruction". Chapter 57, In: Basic Urogynecology, Ed.: Önay Yalçın, Nobel Medicine Bookstore, 2009.
B-3.b. Chapter authoring in translated books
B-3.b.1. P Balkanlı Kaplan, B Tıraş. “Uzun Etkili Kontrasepsiyon Yöntemleri”. In: Speroff L, Fritz MA (Eds). “Clinical Gynecologic Endocrinology & Infertility”. In: Klinik Jinekolojik Endokrinoloji ve İnfertilite, , Erk A, Demirtaş F (Çeviri Eds.), Chapter 24, 7. baskı, Sayfa 950-973, Ankara, Nobel Tıp Kitabevi, 2006.
B-3.b.2. P Balkanli Kaplan, N Ahmet. “Thyroid Diseases”, Ed: AP Kenyon, C Nelson-Piercy, Chapter 46, In: “High risk pregnancy”, Jones D, Ster P, Weiner C, Gonik B (Eds.), Haldun G (Translation Ed.), Pages: 1005-17, Ankara, 3rd edition Güneş Publishing House, 2006.
B-3.b.3. P Kaplan (Assistant translator). Basic knowledge. In: Urogynecology and Pelvic Reconstructive Surgery. Ed: Önay Yalçın. S Siddishi, JS Hardesty. Türkiye clinics, 2007.
B-3.b.4. A Aybatli, P Balkan Kaplan. "Ultrasonic features of infectious diseases in pregnancy" Ed: Ebherhard Merz, In: USG in Obstetrics and Gynecology. 1st Edition, Volume 1, pages 375-81, Güneş Publishing House, 2009.
B-3.b.5. BC Koyuncu, P Balkan Kaplan. ”Benign diseases of the Vulva and Vagina” Turkish Society of Gynecology and Obstetrics 'Current Diagnosis and Treatment' series, In Current Obstetrics and Gynecology diagnosis and treatment', Chapter 37, 11th edition, pages 506-23, Güneş Kitabevi, 2009.
B-6. Article Authoring Published in National Refereed Journals
B-6.1. P Balkanlı Kaplan, NC Dear, F Guger, MA Yüce, T Help. “Effects of Hormone Replacement on Cardiovascular Disease Hemostatic Risk Factors”, Journal of Gynecology and Obstetrics, 14: 155-160 (2000).
B-6.2. NC Sayin, P Balkanli Kaplan, F Guger, MA Yuce, M Ozkok, T Help. “The Prognostic Value of CA 125, α-Fetoprotein, β-HCG, Estradiol and Progesterone in Abortion Immunes Cases”, Turkish Journal of Fertility, 8: 261-272 (2000).
B-6.3. NC Dear, P Balkanlı Kaplan, FG Varol, T Help. “Incidence of Chlamydia Trachomatis Infection in Abortion Immunes Cases”, Journal of Gynecology and Obstetrics, 14: 213-217 (2000).
B-6.4. F Guger, M Yuksel, F Varol, A Yuce, P Balkanli-Kaplan, TF Cermik, T Help. “Maternal serum IL-6 levels in preterm labor and normal delivery”, Turkiye Klinikleri Gynecol Obst, 11: 68-72 (2001).
B-6.5. F Güger, P Balkanlı Kaplan, NC Dear, T Canda, MA Yüce, T Help. “Folic acid use before and during pregnancy in our cases”, Turkish Fertility Journal, 9: 251-257 (2001).
B-6.6. T Yard, P Balkanli-Kaplan, F Guger, M Yuce. “Our Tension-free vaginal tape operation results”, Turkiye Klinikleri J Gynecol Obst, 13: 146-148 (2003).
B-6.7. P Balkanlı-Kaplan, HA Bağrıyanık, F Guger, T Canda, O Yılmaz, MA Yüce. “Effects of Raloxifene co-administration on bone histomorphometric changes in rats treated with GnRHa”, Gynecol Obstet Reprod Med, 11: 99-102 (2005).
B-6.8. MA Yüce, P Balkanlı-Kaplan, F Gucer, NC Sayın, M Yüksel. “A comperative study of effects of tibolone, conjugated equine estrogen alone or combination with medroxyprogesterone acetate on plasma homocysteine levels in postmenopausal women”, Gynecol Obstet Reprod Med, 11: 189-193 (2005).
B-6.9. B Tokuc, P Balkan Kaplan, GO Fish, H Rose. “Quality of life in women admitted to the Trakya University hospital menopause outpatient clinic”. Journal of post-specialist education and current developments, 3(4): 281-8 (2006).
B-6.10. P Balkanlı Kaplan, G Özden, B Tokuç, MA Yüce. “Hormone replacement therapy process and the effects of reproductive factors on bone mineral density in postmenopausal women”, Trakya Univ Medical Faculty Journal, 24(1): 36-42 (2007).
B-6.11. G Yilmaz Aslan, MA Yuce, F Guger, P Balkan Kaplan. “Comparison of oral contraceptive-spironolactone and oral contraceptive-cyproterone acetate combinations in the treatment of hirsutism”, Journal of Gynecology and Obstetrics, Accepted to publication.
B-6.12. G Akgun, N Dairy, P Balkan Kaplan. “The frequency of urinary incontinence and its effects on quality of life in women over 40 years of age”. Turkish clinics Journal of Gynecology and Obstetrics, 20(6): 378-86 (2010).
B-7. Authoring of reviews, technical notes, and case reports published in national peer-reviewed journals
B-7.1. T Help, PB Kaplan. “A case of fetal hydronephrosis detected antenatally”, Journal of Ultrasonography, 2: 123-125 (1998).
B-7.2. P Balkan Kaplan, T Help. “Isolated postpartum rectal lacerations”, Turkiye Klinikleri J Gynecol Obst, 10: 167-171 (2000).
B-7.3. BC Alone, F Guger, P Balkanlı-Kaplan, S Bilgi, T Help. “OEIS Complex (Omphalocele-bladder exstrophy-imperforated anus-spinal defect)”, Turkiye Klinikleri J Gynecol Obst, 11: 233-235 (2001).
B-7.4. R Duran, Ü Vatansever, B Acunaş, P Balkanlı-Kaplan. “A case of Amyoplasia Congenita”, Journal of Children, 3: 225-227 (2003).
B-7.5. P Balkanlı-Kaplan, F Guger. “Laparoscopic pelvic lymph node dissection after incomplete surgery in early stage endometrial cancer”, Trakya Univ Medical Faculty Journal, 22: 106-109 (2005).
B-7.6. P Balkanli Kaplan, B Can. “Overactive bladder and its treatment”. Turkiye Klinikleri Journal of Gynecology and Obstetrics, Special Issue of Urogynecology 48 (3): 24-34 (2007).
B-7.7. P Balkanli Kaplan, A Aybatli. “Pelvic floor functions and physiology” Turkiye Klinikleri Journal of Gynecology and Obstetrics, Special Issue of Pelvic Floor Diseases and Treatment, 2 (2): 8-18 (2009).
B-7.8. A is from Aybat, P is from Balkan. “A 13-14 week old omphalocele case exposed to sodium valproate in utero”. Zeynep Kamil Medical Bulletin; 40-2:79-82 (2009).
B-7.9. A Aybatlı, P Balkan Tiger. “Advanced stage Juvenile granulosa cell tumor of the ovary detected shortly after term pregnancy”. Turkish Journal of Oncology., accepted for publication, 2009.
B-9. In a congress or symposium with a scientific refereeing board organized periodically, every 1-4 years, by a national society or association,
B-9.d. Authorship of poster papers with full text or abstracts
B-9.d.1. PB Kaplan, B Ceylan, T Help. “Effects of hormone replacement containing norethindron on lipid metabolism: oral and transdermal”, Turkish German Gynecology Society Gynecology and Obstetrics Congress. Antalya, 19-23 May 1999.
B-9.d.2. F Powerer, P Kaplan, M Ascend, A Supreme, M Ture, T Help. “Maternal serum Tumor necrosis factor- in patients with preterm labor”, Maternal fetal medicine and perinatology congress, Istanbul, 6-8 April 2000.
B-9.d.3. NC Sayın, F Gücer, MA Yüce, P Balkanlı-Kaplan, M Özkök, T Help. “Serum TNF-α levels in women with normal weight polycystic ovary syndrome (PCOS) and polycystic ovary appearance (PCO)”, TİVAK 2001-IX. Infertility and Reproduction Congress. Ankara, 27-29 October 2001.
B-9.d.4. NC Dear, P Balkanlı Kaplan, F Powerer, A Yüce, T Help. “Heterotopic intrauterine twin pregnancy: presentation of a case”, 'TİVAK 2001' 9th Infertility and Reproduction Congress, Ankara, 27-29 October 2001.
B-9.d.5. P Balkanlı-Kaplan, F Gücer, NC Sayin, M Yuksel, MA Yuce, T Help. “Maternal serum cytokine levels in women with hyperemesis gravidarum”, TİVAK 2002-X. Infertility and Reproduction Congress. Ankara, 26-29 October 2002.
B-9.d.6. T Help, P Balkanlı-Kaplan, F Guger, MA Yüce. “Our Tension-free vaginal tape operation results”, 2nd National Urogynecology Congress, Istanbul, 17-19 April 2002.
B-9.d.7. F Güger, PB Kaplan “Laparoscopic pelvic LND dissection after incomplete surgery”, IX. National Gynecological Oncology Congress, Antalya, 4-8 May 2004.
B-9.d.8. G Ozden, P Balkanli-Tiger. “Our short-term clinical results in the application of Trans-obtrator tape (T.O.T.) in the surgical treatment of female stress incontinence”, 3rd National Urogynecology Congress. Istanbul, 21-23 September 2005.
B-9.d.9. P Balkan Kaplan, G Fish, A Tosun, B Tokuç, B Çakır. “Evaluation of the pelvic anatomical changes of the stress incontinant women after the trans-obtrator tape (TOT) procedure by using magnetic resonance imaging”. 5th National Obstetrics and Gynecology Congress, Antalya, 16-21 May 2006.
B-9.d.10. P Balkanlı Kaplan, A Aybatli, F Guger, MA Yüce. "Our case of epithelial ovarian cancer with brain metastasis, which has a long-term progression-free course after chemotherapy". 5th National Obstetrics and Gynecology Congress, Antalya, 16-21 May 2006.
B-9.d.11. N Kıyak, H Tezcanlı, P Balkan Kaplan. "Combined use of high sacrouterine suspension and Mc Call culdoplasty during vaginal hysterectomy: results". 1. Pelvic floor Diseases and Voiding Disorders Congress, Antalya, 30 October-3 November 2007.
B-9.d.12. Aybatlı A, M Alicik, P Balkanlı Kaplan, NC Sayin. “Evaluation of treatment options in ectopic pregnancy cases”. 6th National Gynecology and Obstetrics Congress, Antalya, 14-19 May 2008.
B-9.d.13. Aybatli A, P Balkan Kaplan. “A 13-14 week old omphalocele case exposed to valproate in utero: Case report”. 6th National Gynecology and Obstetrics Congress, Antalya, 14-19 May 2008.
B-9.d.14. Koyuncu BC, P Balkan Kaplan, M Kaplan. “Primary pelvic hydatid cyst causing urinary dysfunction”. 7th National Gynecology and Obstetrics Congress, Kyrenia, TRNC, 14-19 May 2009.
B-9.d.15. Koyuncu BC, P Balkan Kaplan. “Giant ovarial serous cystadenoma that completely fills the abdomen and creates stasis edema in the leg”. 7th National Gynecology and Obstetrics Congress, Kyrenia, TRNC, 14-19 May 2009.
B-9.d.16. Koyuncu BC, P Balkanlı Kaplan, MA Yüce. “A case of leiomyoma originating from the vaginal stroma”. 7th National Gynecology and Obstetrics Congress, Kyrenia, TRNC, 14-19 May 2009.
B-9.d.17. P Balkanlı Kaplan, U Usta, HA Inal, T Taştekin, B Tokuc. "Neuromuscular morphometry of the uterine ligaments and vaginal wall in women with pelvic organ prolapse". IV. National Urogynecology Congress, Istanbul, 21-24 October 2009.
B-9.d.18. P Kaplan, MA Supreme. “Our results of vaginal obliterative operations in women with advanced prolapse and their comparison with non-obliterative methods”. IV. National Urogynecology Congress, Istanbul, 21-24 October 2009.
B-9.d.19. G Akgun, P Balkan Kaplan. “The frequency of urinary incontinence and its effects on quality of life in women over 40 years of age in the Thrace region”. IV. National Urogynecology Congress, Istanbul, 21-24 October 2009.
B-9.d.20. H Kahyaoğlu Süt, S Tekbaş, P Balkan Kaplan. “Evaluation of overactive bladder frequency and quality of life”. 8. National Gynecology and Obstetrics Congress, Antalya, 18-23 May 2010.
B-9.d.21. S Avcıoğlu Tekbaş, H Kahyaoğlu Süt, P Balkanlı Kaplan. “Quality of life in patients diagnosed with gynecological cancer and in treatment”. 8. National Gynecology and Obstetrics Congress, Antalya, 18-23 May 2010.
B-9.d.22. S Avcıoğlu Tekbaş, H Kahyaoğlu Süt, P Balkanlı Kaplan. “Post-operative blood picture changes in patients who have undergone gynecological surgery”. 8. National Gynecology and Obstetrics Congress, Antalya, 18-23 May 2010.
B-9.d.23. P Balkanlı Kaplan, H Kahyaoğlu Süt, N Süt. ”Correlation of luts severity between free-flow and cystometric bladder volumes”. 5. National urogynecology congress, Istanbul, 19-21 October 2011.
B-9.d.24. P Balkanlı Kaplan, H Kahyaoğlu-Süt, N Süt. ”The correlation of uroflowmetric data and urethral pressure profilometry values in women with stress urinary incontinence” 5th National urogynecology congress, Istanbul, 19-21 October 2011.
B-9.d.25. H Kahyaoğlu-Milk, P Balkan Kaplan. “Relationship between anterior vaginal wall prolapse and urinary symptoms” 5th National urogynecology congress, Istanbul, 19-21 October 2011.
B-9.d.26. H Kahyaoğlu-Milk, P Balkan Kaplan. “Urethral pressure profilometry in cases with anterior vaginal prolapse” 5th National urogynecology congress, Istanbul, 19-21 October 2011.
C- Reviewing, Editing, and Other Activities
C-2. In peer-reviewed journals scanned by Science Citation Index (SCI), SCI-Expanded, Social Science Citation Index (SSCI) and Art And Huminities Citation Index (AHCI);
c- Refereeing
1. Balkan Medical Journal (2010-2011)
2. International Journal of Urogynecology (2010)
3. Gynecologic and Obstetric Investigation (2011)
C-3. In peer-reviewed international journals that are not scanned by the Science Citation Index (SCI), SCI-Expanded, Social Science Citation Index (SSCI) and Art And Huminities Citation Index (AHCI);
c- Refereeing
1. Journal of the Turkish German Gynecological Association (2009-)
2. McMaster Online Rating of Evidence (MORE) (2006-)
C-4. In a refereed congress or symposium held periodically in all international or abroad held in Turkey;
a- Editorship, congress chairmanship and secretariat
C-4.a.1. Pelvic Floor Function and Dysfunction Symposium, Chairman of the Symposium, 22-23 September 2010, Edirne.
C-4.a.2. 1. Balkan Pelvic Floor Diseases Symposium, Congress Secretariat, 1-3 March 2011, Edirne.
b- Panel chairman, panelist or speaker
C-4.b.1. 5th International Reproductive Health and Family Planning Congress, Scientific committee membership and speaker Subject: Osteoporosis treatments, 19-22 April 2007, Ankara.
C-4.b.2. 7. International Reproductive Health and Family Planning Congress, (speaker). Subject: Contraception in Systemic Diseases, 22-25 April 2009, Ankara.
c- Session Chairman or co-chairman
C-4.c.1. IV. International Reproductive Health and Family Planning Congress, 22 April 2005, Ankara. Free papers (Presidency of Session)
C-6. In the journals in the TUBITAK index;
b. Editorial assistant or Editorial Board Member
C-6.b.1. Turkish Clinics Journal of Gynecology and Obstetrics (2008-)
c. Refereeing
C-6.c.1. Turkish Clinics Journal of Gynecology and Obstetrics (2008-)
C-7. In National Refereed Journals,
c. Refereeing
C-7.c.1. Trakya University Medical Faculty Journal (2006,2007)
C-8. At a peer-reviewed congress or symposium periodically organized by a national society or organization;
b. Panel Chair, Panelist or speaker
C-8.b.1. III. Urogynecology post-graduation course, roundtable session titled 'Urogynecology in Turkey' (speaker) Istanbul Faculty of Medicine, February 22, 2001, Istanbul.
C-8.b.2. V. National Congress of Gynecology and Obstetrics, (Speaker) Topic: Evaluation of quality of life and symptoms in urogynecology. 16-21 May 2006, Antalya.
C-8.b.3. V. National Congress of Gynecology and Obstetrics, Urogynecology course (speaker) Topic: Urodynamic examination. When? How? 16-21 May 2006, Antalya.
C-8.b.4. TÜJD Urinary Incontinence Symposium, (Speaker) Topic: Evaluation and staging of POP cases, 16 November 2006, Istanbul.
C-8.b.5. TJOD Edirne Regional Meeting (speaker) Topic: Current treatments in osteoporosis: When to wait, when to medication. 10 June 2007, Istanbul.
C-8.b.6. TJOD Trabzon regional meeting (Speaker) Topic: Evaluation of patients with urinary incontinence; clinical and laboratory tests. September 9, 2007, Trabzon.
C-8.b.7. TJOD National Education Symposium, Urogynecology course. (Speaker) Topic: Evaluation of quality of life and symptoms in urogynecology. 25 October 2007, Antalya.
C-8.b.8. TJOD National Education Symposium, (Speaker) Topic: Evaluation of quality of life and symptoms in urogynecology. 29 October 2007, Antalya.
C-8.b.9. I. Pelvic Floor Health and Voiding Disorders Congress. (Speaker) Topic: Behavioral treatment methods in urinary incontinence, 30 October- 3 November 2007, Antalya.
C-8.b.10. TJOD-Edirne Regional Meeting (Speaker) Topic: HPV vaccines-Latest data, 2.12.2007, Lüleburgaz, Kırklareli.
C-8.b.11. 6th National Congress of Gynecology and Obstetrics, (Speaker) Topic. How should the minimal evaluation be in urinary incontinence? 14-19 May 2008, Antalya.
C-8.b.12. TJOD Symposium, (Speaker) Topic: Pelvic sagging and its treatments, current approach. November 22, 2008, Ankara.
C-8.b.13. TJOD-Istanbul Branch, Urogynecology course, (Speaker) Subject: Head suspension methods after vaginal hysterectomy, 27 December 2008, Istanbul.
C-8.b.14. 7th National Gynecology and Obstetrics Congress, (Speaker and Course Instructor)
Subject. Evaluation of symptoms and quality of life in urinary incontinence,
14-19 May 2009, Cyprus.
C-8.b.15. TJOD-Edirne branch regional meeting- Urogynecology and pelvic floor (speaker) Topic: Can cuff prolapse be prevented after hysterectomy?
June 7, 2009, Edirne.
C-8.b.16. IV. National Urogynecology Congress, (Speaker)
Subject: Diagnosis and approach in occult urinary incontinence. 21-24 October 2009, Istanbul.
C-8.b.17. Surgical kit (Prolift+M) usage course in the treatment of pelvic organ prolapse, (Speaker) Topic: Pelvic anatomy for prolapse surgery. 21-22 January 2010, Istanbul.
C-8.b.18. Urogynecology controversial issues symposium (Speaker)
Subject: A case report of prolapse treatment in young women, 23-24 January 2010, Istanbul
C-8.b.19. Gynecological endoscopy symposium and workshop (Course training)
Subject: Evaluation of a patient with urinary incontinence, 11 February 2010, Bursa.
C-8.b.20. Gynecological endoscopy symposium and workshop (Congress panelist)
Subject: Evaluation of a patient with urinary incontinence, 12 February 2010, Bursa.
C-8.b.21. New techniques course in stress urinary incontinence and pelvic organ prolapse surgery (course trainer) Topic:Mesch treatment complications, what are the preventive measures? 04-05 March 2010, Istanbul
C-8.b.22. Tekirdağ primary level education days (Speaker)
Subject: Genital cancers, 16-18 April 2010, Tekirdag
C-8.b.23. 8th TJOD National Congress (Speaker)
Subject: Surgical treatment of prolapse cases; vaginal approach, 18-22 May 2010, Antalya
C-8.b.24. Preservation of the pelvic floor during pregnancy and childbirth - Multidisciplinary approach course (speaker) Topic: What is urogynecology? Anatomy of the pelvic floor and pelvic organs
23-25 September 2010, Istanbul
C-8.b.25. Current approaches and surgical applications course in urogynecology (speaker)
Subject: In which cases should we use mesh for pelvic floor repair? 3-4 December 2010, Ankara.
C-8.b.26. TJOD Edirne Branch Meeting (Speaker) Topic: Approach to prolapse cases, obliterative methods, February 27, 2011, Çerkezköy / Tekirdağ
C-8.b.27. Istanbul University Women's Birthdays meeting (speaker)
Subject: Pharmacological treatment of urinary incontinence. How real is which treatment?
11-13 March 2011, Istanbul
C-8.b.28. Experimental animals use certificate course (Course Trainer). Subject: Animal models used in experimental research. 14 February-11 May 2011, Edirne.
C-8.b.29. 9th national gynecology and obstetrics congress (speaker)
Subject: Obliterative methods in prolapse surgery, 18-23 May 2011 Antalya.
C-8.b.30. 5th National Urogynecology Congress, Urogynecology course (Speaker). Subject: Patient Evaluation, 19-21 October 2011, Istanbul.
C-8.b.31. Palandoken Obstetrics and Gynecology Congress (Speaker)
Subject: The role of conservative treatment in POP, 1-4 March 2012, Erzurum
c. Session Chairman or co-chairman
C-8.c.1. TJOD Edirne Regional meeting. Meeting coordinator, Session Chair.
10 June 2007, Istanbul.
C-8.c.2. TJOD National Education Symposium, Urogynecology course. Session Chairperson,
25 October 2007, Antalya.
C-8.c.3. I. Pelvic Floor Health and Voiding Disorders Congress. Session Chairperson,
30 October - 3 November 2007, Antalya.
C-8.c.4. Current approaches and surgical practices in urogynecology course. Chairman of the Session, 3-4 December 2010, Ankara.
C-8.c.5. TÜBAP Scientific Research Introductory Seminars (Coordination and moderator)
February 26, 2011, Edirne
D. Scientific Citations
D-1. Each citation given in scientific, professional and textbooks published or accepted to be published by international publishing houses
D-1.1.
Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. Eds: Maureen Paul, Steve Lichtenberg. Chapter 15. Surgical Complications: Prevention and Management, Wiley-Blackwell, 2009, ISBN-10: 1405176962, page 249
A-4.4.
D-1.2.
Placenta: Webster's Timeline History, 2005 - 2007. Eds: Icon group International. 2009, ISBN-10: 0546893821, page 21
A-4.4.
D-1.3.
Insulin Resistance and Polycystic Ovarian Syndrome: Pathogenesis, Evaluation, and Treatment. Eds: Evanthia Diamanti-Kandarakis, John E. Nestler, Dimitrios Panidis and Renato Pasquali. Humana press, 2010, ISBN-10: 1617377635 Page 190
A-3.7.
D-1.4.
Recurrent Miscarriage And Pre-eclampsia: The Roles Played By The Immune System And Antioxidants. Ed: Rhoda Wilson, World Scientific Pub Co Inc, 2004, ISBN-10: 9812388508
A-3.4.
D-1.5.
Clinical Endocrine Oncology. Eds. Ian D. Hay and John A. H. Wass. Wiley-Blackwell; 2 edition, 2008, ISBN-10: 1405145846, page 392
A-4.1.
D-1.6.
Blaustein's Pathology of the Female Genital Tract. Eds. Robert J. Kurman, Lora Hedrick Ellenson and Brigitte M. Ronnett
Soft Tissue Lesions Involving Female Reproductive Organs, John F. Fetsch and William B. Laskin. Springerlink; 2011, DOI: 10.1007/978-1-4419-0489-8_22, page 1159-1203,
A-4.1.
D-1.7.
• Polycystic Ovary Syndrome: A Guide to Clinical Management. Eds: Adam Balen, Gerard S. Conway, Roy Homburg and Richard S. Legro. Informa Healthcare,2004, ISBN-10: 1842142119 page 104
A-3.8.
D-2. Each citation in peer-reviewed journals scanned by the Science Citation Index (SCI), Social Science Citation Index (SSCI), and Arts and Huminities Citation Index (AHCI)
D-2.1.
Buka SL, Tsuang MT, Torrey EF, et al. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 15: 411-420 (2001).
A-3.1.
D-2.2.
Hassan MI, Aschner Y, Manning CH, et al. Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. Cytokine 21:10-16 (2003).
A-3.1.
D-2.3.
Hasegawa K, Fruichi Y, Shimotsu A, et al. Associations between systemic status, periodontal status, serum cytokine levels and delivery outcomes in pregnant women with a diagnosis of threatened premature labor. J Periodontology 74: 1764-1770 (2003).
A-3.1.
D-2.4.
Bauer S, Pollheimer J, Hartmann J, et al. Tumor necrosis factor-alpha inhibitors trophoblast migration through elevation of plasminogen activator inhibitor-1 in first trimester villous explant cultures. J Clin Endocrinol Metab 89: 812-822 (2004).
A-3.1.
D-2.5.
Valdez LL, Quintero A, Garcia E, et al. Thrombophilic polymorphisms in preterm delivery. Blood cells Mol Dis 33: 51-56 (2004).
A-3.1.
D-2.6.
Aaltonen R, Heikkinen TA, Hakala K, et al. Transfer of proinflammatory cytokines across term placenta. Obstet Gynecol 106: 802-807 (2005).
A-3.1.
D-2.7.
Tse KY, Ho LF, Lao T. The impact of maternal HbsAg carrier status on pregnancy outcomes: A case-control study. J Hepatol 43: 771-775 (2005).
A-3.1.
D-2.8.
Huber AV, Saleh L, Bauer S, et.al. TNF-alpha-mediated induction of TAI-1 restricts invasion of HTR-8/SVneo trophoblast cells. Placenta 27 (2-3): 127-36 (2006).
A-3.1.
D-2.9.
Parry S, Zhang J, Koi H, et.al. Transcytosis of human immunodeficiency virus 1 across the placenta is enhanced by treatment with tumor necrosis factor alpha. J General Virology 87 (8): 2269-78 (2006).
A-3.1.
D-2.10.
Vitoratos N, Papadias K, Makrakis E, et.al. Association between serum tumor necrosis factor-alpha and corticotrophin-releasing hormone levels in women with preterm labor. J Obstet Gynecol Res 32 (6): 497-501 (2006).
A-3.1.
D-2.11.
Harry GJ, Lawler C, Brunssen SH. Maternal infection and white matter toxicity. Neurotoxicology 27 (5): 658-70 (2006).
A-3.1.
D-2.12.
Vitoratos N, Kountouris A, Makrakis E, et.al. No effect of tocolytic therapy with atosiban on maternal serum interleukin-6 and tumor necrosis factor-alpha in threatened preterm labor. J Mat-fetal-Neonate Med 20 (10): 725-8 (2007).
A-3.1.
D-2.13.
Elovitz MA, Gonzalez J. Medroxyprogesterone acetate modulates the immune response in the uterus, cervix and placenta in a mouse model of preterm birth. J Maternal-fetal Neonatal Med 21 (4): 223-30 (2008).
A-3.1.
D-2.14.
Fabris A, Catamo E, Segat L, et.al. Association between HLA-G 3 UTR 14-bp polymorphism and HIV vertical transmission in Brazillaian children. AIDS 23 (2): 177-82 (2009).
A-3.1.
D-2.15.
Pearce B. D.; Grove J.; Bonney E. A.; et al. Interrelationship of Cytokines, Hypothalamic-Pituitary-Adrenal Axis Hormones, and Psychosocial Variables in the Prediction of Preterm Birth
Gynecol Obstet Invest 70(1): 40-46 (2010)
A-3.1.
D-2.16.
Yuce MA, Kaplan PB, Gucer F, et al. Prevention of cyclophosphamide-induced ovarian damage by concomitant administration of GnRHa in mice: a dose-dependent relationship? Eur J Gynaecol Oncol 25: 628-631 (2004).
A-3.2.
D-2.17.
Yücebilgin MS, Terek MC, Özsaran A, et al. Effect of chemotherapy on primordial follicular reserve of rat: An animal model of premature ovarian failure and infertility. Aust N Z J Obstet Gynecol 44: 6-9 (2004).
A-3.2.
D-2.18.
Anderson RA, Themmen APN, Al-Qahtani A, et.al. The effect of chemotherapy and long term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 21(10): 2583-92 (2006).
A-3.2.
D-2.19.
Ozcelik Bulent; Turkyilmaz Contemporary; Ozgun Mahmut Tuncay; et al. Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist. Fertile Sterile 93(5): 1609-1614 (2010)
A-3.2.
D-2.20.
Lee Y, Lee O, Cho J, et al. Ultrasonic measurement of fetal parameters for estimation of gestational age in Korean black goats. J veterinary med science 67: 497-502 (2005).
A-3.3.
D-2.21.
Ozat Mustafa; Kanat-Pektas Mine; Gungor Typhoon; et al. The significance of fetal sacral length in the ultrasonographic assessment of gestational age
Arch Gynecol Obstet 283(5): 999-1004 (2011)
A-3.3.
D-2.22.
Yamada H, Morikawa M, Furuta I, et al. Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood. Am J Reprod Immunol 49: 84-89 (2003).
A-3.4.
D-2.23.
Paradisi R, Porcu E, Venturoli S, et al. Maternal serum levels of pro-inflammatory cytokines in missed and threatened abortion. Am J Reprod Immunol 50:302-308 (2003).
A-3.4.
D-2.24.
Kaplan PB; Gucer F; Dear NC; et al. Maternal serum cytokine levels in women with hyperemesis gravidarum in the first trimester of pregnancy Fertile Sterile 79(3): 498-502 (2003)
A-3.4.
D-2.25.
Brown AS, Hooton J, Schaefer CA, et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 161: 889-895 (2004).
A-3.4.
D-2.26.
Balkanli-Kaplan P; Gucer F; Yuce MA T-helper 2-cytokine levels in women with threatened abortion Eur J Obstet Gynecol Reprod Biol 114(2): 239-240 (2004)
A-3.4.
D-2.27.
Fasouliotis SJ, Spandorfer SD, Witkin SS, et al. Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies. Hum Reprod 19: 1357-1363 (2004).
A-3.4.
D-2.28.
Paradisi R. T-helper 2-cytokine levels in women with threatened abortion. Eur J Obstet Gynecol Reprod Biol 114: 241-241 (2004).
A-3.4.
D-2.29.
Yu YW, Yan CF, Jin H, et al. Tumor necrosis factor receptor 1 expression and early spontaneous abortion. Int J Gynecol Obstet 88: 44-48 (2005).
A-3.4.
D-2.30.
Klimek M, Wicherek L, Popiela TJ, et al. Changes of maternal ACTH and oxytocinase plasma concentrations during the first trimester of spontaneous abortion. Neuroendocrinol letters 26: 342-346 (2005).
A-3.4.
D-2.31.
Klimek M. Comparative analysis of ACTH and oxytocinase plasma concentration during pregnancy. Neuroendocrinol Letters 26: 337-341 (2005).
A-3.4.
D-2.32.
Kalinka J, Radwan M. The impact of dydrogesterone supplementation on serum cytokine profile in women with threatened abortion. Am J Reprod Immunol 55 (2): 115-21 (2006).
A-3.4.
D-2.33.
Yu XW, Wang LQ, Yan CF, et.al. Expression and localization of tumor necrosis factor receptor 1 protein in the chorionic villi in early normal and spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 132 (1): 58-63 (2007).
A-3.4.
D-2.34.
Szekeres-Bartho J, Wilczynski JR, Basta P, et.al. Role of progesterone and progestin therapy in threatened abortion and preterm labor. Front Bioscience 13: 1981-90 (2008).
A-3.4.
D-2.35.
Wicherek L. The role of the endometrium in the regulation of immune cell activity. Front Bioscience 13: 1018-35 (2008).
A-3.4.
D-2.36.
Raghupathy R, Kalinka J. Cytokine imbalance in pregnancy complications and its modulation. Front Bioscience 13:985-94 (2008).
A-3.4.
D-2.37.
Morelli SS, Keegan DA, Krey LC, et.al. Early Serum interleukin-8 evaluation may prove useful in localizing abnormally implanted human gestations after in vitro fertilization. Fertile Sterile 90 (6): 2068-72 (2008).
A-3.4.
D-2.38.
Romero Roberto; Until Nicholas; Vaisbuch Edi; et al. Maternal Death Following Cardiopulmonary Collapse After Delivery: Amniotic Fluid Embolism or Septic Shock Due to Intrauterine Infection? Am J Reprod Immunol 64(2): 113-125 (2010)
A-3.4.
D-2.39.
Williams MS, Vaidya D, Klickler T, et al. Long-term hormone replacement therapy does not cause increased platelet activation. Am Heart J 150: 434-438 (2005).
A-3.5.
D-2.40.
Robert Flaumenhaft; Nachtigall Margaret; Lowenstein Joanna; et al. Association of oral but not transdermal estrogen therapy with enhanced platelet reactivity in a subset of postmenopausal women Menopause 16(2): 407-412 (2009)
A-3.5.
D-2.41.
Yoneyama Y, Suzuki S, Sawa R, et al. Plasma adenosine concentrations increase in women with hyperemesis gravidarum. Clinica Chimical Acta 342: 99-103 (2004).
A-3.6.
D-2.42.
Outlaw WM, Ibdah JA. Impaired fatty acid oxidation as a cause of liver disease associated with hyperemesis gravidarum. Med Hypothses 65: 1150-1153 (2005).
A-3.6.
D-2.43.
Verberg MFG, Gillott DJ, Al-Fardan N, et al. Hyperemesis gravidarum, a literature review. Hum Reprod Update 11: 527-539 (2005).
A-3.6.
D-2.44.
Yoneyama Y, Suzuki S, Sawa R, et al. Plasma adenosine concentrations increase in women with hyperemesis gravidarum. Clinica Chimical Acta 352: 75-79 (2005).
A-3.6.
D-2.45.
Agren A, Berg M. Tactile massage and severe nausea and vomiting during pregnancy-women's experiences. Scan J Caring Science 20 (2): 169-76 (2006).
A-3.6.
D-2.46.
Joanna Tkaczuk-Włach, Dorota Robak-Chołubek, Grzegorz Jakiel. Niepłodność męska. Przegląd Menopauzalny 5: 333-338 (2006)
A-3.6.
D-2.47.
T. Murphy Goodwin. Hyperemesis Gravidarum. Obstet Gynecol Clin North Am. 35 (3): 401-417 (2008)
A-3.6.
D-2.48.
Lee NM, Brady CW. Liver Disease in pregnancy. World J Gastroenterol 15 (8): 897-906 (2009).
A-3.6.
D-2.49.
Pan Calvin; Perumalswami Ponni V. Pregnancy-Related Liver Diseases Clin Liver Disease 15(1):199 (2011)
A-3.6.
D-2.50.
Sanu Olalee; Lamont Ronald F. Hyperemesis gravidarum: pathogenesis and the use of antiemetic agents
Exp Opin Pharmacotherapy 12(5): 737-748 (2011)
A-3.6.
D-2.51.
Sonkusare Shipra. The clinical management of hyperemesis gravidarum Arch Gynecol Obstet 283(6):1183-1192 (2011)
A-3.6.
D-2.52.
Lee Noel M.; Field Sumona. Nausea and Vomiting of Pregnancy
Gastroenterol Clin North Am 40(2): 309 (2011)
A-3.6.
D-2.53.
Mullin PM, Ching CY, Schoenberg F, MacGibbon K, Romero R, Goodwin TM, Fejzo MS. Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum. J Maternal-Fetal and Neonatal Medicine, 1-5 (2011)
A-3.6.
D-2.54.
Luchetti CG, Solano ME, Sander V, et al. Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function. J Reprod Immunol 64:59-74 (2004).
A-3.7.
D-2.55.
Puder JJ, Varga S, Kraenzlin M, et al. Central fat excess in polycystic ovary syndrome: Relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab 90: 6014-6021 (2005).
A-3.7.
D-2.56.
Gonzalez F, Minium J, Rote NS, et al. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90: 5336-5342 (2005).
A-3.7.
D-2.57.
Sander V, Luchetti CG, Solano ME, et.al. Role of the NN'-dimethylbiguanide metformin in the treatment of female prepuberal Balb/C mice hyperandrogenized with dehydroepiandrosterone. Reproduction 131 (3): 591-602 (2006).
A-3.7.
D-2.58.
Solano ME, Elia E, Luchetti CG, et.al. Metformin prevents embryonic resorption induced by hyperandrogenisation with dehydroepiandrosterone in mice. Reprod Fertil Develop 18(5): 533-44 (2006).
A-3.7.
D-2.59.
Warren-Ulanch J, Arslanian S. Treatment of PCOS in adolecence. Best Prac Res Clin Endocrinol Metab 20 (2): 311-30 (2006)
A-3.7.
D-2.60.
Vgontzas AN, Trakada G, Bixler EO, et.al. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of pbesity or sleep apnea. Metab Clin Experiment 55 (8): 1076-82 (2006).
A-3.7.
D-2.61.
Zhang YF, Yang YS, Hong J, et.al. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 29 (3): 419-23 (2006).
A-3.7.
D-2.62.
Li WP, Cheng QF, Ma SK, et.al. Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 30 (3): 283-7 (2006).
A-3.7.
D-2.63.
Lenarcik A, Bidzinska-Speichert B. The role of inflammatory markers, hemostasis factors and oxidative stress in the pathogenesis of polycystic ovary syndrome. Name Clin Exper Med 16 (2): 317-22 (2007).
A-3.7.
D-2.64.
Yıldız BO, Knochenhauer ES, Aziz R. Impact of obesity on the risk for poltcystic ovary syndrome. J Clin Endocrinol Metab 93 (1): 162-8 (2008).
A-3.7.
D-2.65.
Jakubowska J, Bohdanowicz-Pawlak A, Milawicz A, et.al. Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment. Gynecol Endocrinol 24 (7): 378-84 (2008).
A-3.7.
D-2.66.
Goodarzi MO, Maher JF, Cui J, et.al. FEM1A and FEM1B: Novel candidate genes for polycystic ovary syndrome. Hum Reprod 23 (12): 2842-9 (2008).
A-3.7.
D-2.67.
Sangraula H.; Paudel K. R.; Sharma M. Metformin and Troglitazone in the Treatment of Female Infertility Associated with Polycystic Ovarian Syndrome J Nepal Med Assoc 48(4): 335-339 (2009)
A-3.7.
D-2.68.
Motta A. B. Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome
J Steroid Biochem Mol Biol 119(3-5): 105-111 (2010)
A-3.7.
D-2.69.
Kim Yongjin; Ku Seung-Yup; Jee Byung Chul; et al. A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles
Arch Gynecol Obstet 282(2): 199-205 (2010)
A-3.7.
D-2.70.
Lenarcik Agnieszka; Bidzinska-Speichert Bozena; Tworowska-Bardzinska Urszula. The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome Gynecol Endocrinol 26(9): 673-683 (2010)
A-3.7.
D-2.71.
Escobar-Morreale Hector F.; Luque-Ramirez Manual; Gonzalez Frank. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
Fertile Sterile 95(3): 1048-U249 (2011)
A-3.7.
D-2.72.
Toulis Konstantinos A.; Goulis Dimitrios G.; Mintziori Gesthimani; et al. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome
Hum Reprod Update 17(6): 741-760 (2011)
A-3.7.
D-2.73.
Solano ME, Sander VA, Ho H, Motta AB, Arck PC. Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS). J Reprod Immunol 92 (1-2): 33-44 (2011)
A-3.7.
D-2.74.
Engin-Üstüen Y, Ustun Y, Meydanlı MM, et.al. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome? Gynecol Endocrinol 22(6): 324-8 (2006).
A-3.8.
D-2.75.
Amato MC, Galluzzo A, Merlino S, et.al. Lower insulin sensitivity differentiates hustle from non-hirsute Sicilian women with polycystic ovary syndrome. Eu J Endocrinol 155(6): 859-65 (2006).
A-3.8.
D-2.76.
Sir-Petermann T, Echiburu B, Maliqueo MM, et. get. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum Reprod 22(7): 1830-6 (2007).
A-3.8.
D-2.77.
Battaglia C, Mancini F, Cianciosi A, et.al. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome. Obstet Gynecol 111(2): 385-95 (2008).
A-3.8.
D-2.78.
Recaberran SE, Smith R, Rios R, et.al. Metabolic profile in sons of women with polycystic ovary syndrome. J Clin Endocrinol Metab 93(5): 1820-6 (2008).
A-3.8.
D-2.79.
Westerveld HE, Hoogendoom M, Dejong AWF, et.al. Cardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapic insights. Pharma Ther 119(3): 223-41 (2008).
A-3.8.
D-2.80.
Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary sendrome. Fertil Steril 15(4): 477-88 (2009).
A-3.8.
D-2.81.
Battaglia C, Mancini F,Cianciosi A,Busacchi P, Persico N, Paradisi R, Facchinetti F, de Aloysio D. Cardiovascular risk in normal weight, eumenorrheic, nonhirsute daughters of patients with polycystic ovary syndrome: a pilot study. Fertil Steril 92(1): 240-249 (2009)
A-3.8.
D-2.82.
Maliqueo M, Echiburu B, Crisosto N, et.al. Metabolic parameters in cord blood of newborns of women with polycystic ovary sendrome. Fertil Steril 92(1): 277-82 (2009).
A-3.8.
D-2.83.
Swanton Alexander; Storey Lisa; McVeigh Enda; et al. IVF outcome in women with PCOS, PCO and normal ovarian morphology Eur J Obstet Gynecol Reprod Biol 149( 1): 68-71, (2010)
A-3.8.
D-2.84.
Rachon Dominik; Teede Helena Ovarian function and obesity-Interrelationship, impact on women's reproductive lifespan and treatment options Mol Cell Endocrinol 316(2): 172-179 (2010)
A-3.8.
D-2.85.
Perez-Bravo Francisco; Carrasco Elena; Echiburu Barbara; et al. Serological markers of autoimmunity in pregnant women with polycystic ovary syndrome: a pilot study Gynecol Endocrinol 26(12): 889-893 (2010)
A-3.8.
D-2.86.
Battaglia Cesare; Battaglia Bruno; Mancini Fulvia; et al. Ultrasonographic extended-view technique for evaluation of abdominal fat distribution in lean women with polycystic ovary syndrome Acta Obstet Gynecol Scand 90(6): 600-608 (2011)
A-3.8.
D-2.87.
Cakal Erman; Ustun Yusuf; Engin-Ustun Yaprak; et al. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome Gynecol Endocrinol 27(7): 491-495 (2011)
A-3.8.
D-2.88.
Swanton Alexander; Lighten Antony; Granne Ingrid; et al. Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial Human Reprod 26(8): 2178-2184 (2011)
A-3.8.
D-2.89.
Van Geijn HP, Lenglet JE, Bolte AC. Nifedipine trials: effectiveness and safety aspects. BJOG 112 (Suppl. 1): 79-83 (2005).
A-3.9.
D-2.90.
Oei SG. Calcium channel blockers for tocolysis: A review of their role and safety following reports of serious adverse events. Eur J Obstet Gynecol Reprod Biol 126 (2): 137-45 (2006).
A-3.9.
D-2.91.
Cararach V, Palacio M, Martinez S, et.al. Nifedipine versus ritodrine for suppression of preterm labor-Comparison of their efficacy abd secondary effects. Eur J Obstet Gynecol Reprod Biol 127 (2): 204-8 (2006).
A-3.9.
D-2.92.
Kim A, Shim JY. Emerging tocolytics for maintenance therapy of preterm labour:oxytocin antagonists and calcium cannel blockers. BJOG-Int J Obstet Gynecol 113 (3): 113-5 (2006).
A-3.9.
D-2.93.
Jacquemyn Y. Use of tocolytics: what is the benefit of gaining even more time? . BJOG-Int J Obstet Gynecol 113 (3): 78-80 (2006).
A-3.9.
D-2.94.
Groom KM. Pharmacological prevention of prematurity. Best Pract Res Clin Obstet Gynecol 21 (5): 843-56 (2007).
A-3.9.
D-2.95.
Lyell DJ, Pullen KM, Mannan J, et.al. Maintenance nifedipine tocolysis compared with placebo a randomized controlled trial. Obstet Gynecol 112 (6): 1221-6 (2008).
A-3.9.
D-2.96.
de la Torre L, Istwan NB, Desch C, et.al. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis. Am J Perinatol 25 (9): 555-60 (2008).
A-3.9.
D-2.97.
Honest H, Forbes CA, Duree KH, et.al. Screening to prevent spontaneous preterm birth: systemic reviews of accuracy and effectiveness literature with economic modelling. Health Tech Assess 13 (43):1 (2009).
A-3.9.
D-2.98.
Sayin N. Cenk; Arda Sezer; Varol Fusun G.; et al. The effects of ritodrine and magnesium sulfate on maternal and fetal Doppler blood flow patterns in women with preterm labor
Eur J Obstet Gynecol Reprod Biol 152(1): 50-54 (2010)
A-3.9.
D-2.99.
Nassar Anwar H.; Aoun Joelle; Usta Ihab M. Calcium Channel Blockers for the Management of Preterm Birth: A Review
Am J Perinatol 28(1): 57-65 (2011)
A-3.9.
D-2.100.
Conde-Agudelo Agustin; Romero Roberto; Kusanovic Juan Pedro. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol 204(2) 134.e1 2011
A-3.9.
D-2.101.
Loverro G, Guarini A, Di Naro E, et.al. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology 12 (2): 141-7 (2007).
A-3.10.
D-2.102.
Loverro G ; Guarini A;Di Naro E; Giacomantonio L;Lavopa C; Liso V. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology 12 (2): 141-147 (2007)
A-3.10.
D-2.103.
Blumenfeld Z, Avivi I, Eckman A, et.al. Gonadotropin-releasing hormone agonist dereases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89 (1): 166-73 (2008).
A-3.10.
D-2.104.
Meistrich ML, Shetty G. Hormonal suppression for fertility preservation in males and females. Reproduction 136 (6): 691-701 (2008).
A-3.10.
D-2.105.
Rosendahl Mikkel; Ahlgren Johan; Andersen Jorn; et al. The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: Data from the randomised SBG 2000-1 study. Eur J Cancer 45(18): 3198-3204 (2009)
A-3.10.
D-2.106.
Khorana AA, Francis CW, Culakova E, et al. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 104: 2822-2829 (2005).
A-3.11.
D-2.107.
Iwasaki A, Hamanaka W, Hamada T, et.al. Significance of platelet counts in patients who underwent surgical treatment for lung metastasis. Int Surgery 92(2):103-9 (2007).
A-3.11
D-2.108.
Heras Panagiotis; Hatzopoulos Antonios; Kritikos Nikolaos; et al. Platelet count and tumor progression in gastric cancer patients
Scan J Gastroenterology 45( 7-8): 1005-1006 (2010)
A-3.11.
D-2.109.
Lee Maria; Kim Sang Wun; Nam Eun Ji; et al. The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer Gynecol Oncol 122(2): 238-241 (2011)
A-3.11.
D-2.110.
Feifer Andrew; Corcos Jacques. The use of synthetic sub-urethral slings in the treatment of female stress urinary incontinence Int Urogynecol J 18(9): 1087-1095 (2007)
A-3.12.
D-2.111
Gamble T.; Sand P. K. Evaluation and treatment of female urinary incontinence Panminerva Medica 49(3): 159-175 (2007)
A-3.12.
D-2.112
Siddighi Sam; Karram Mickey M. Surgical and nonsurgical approaches to treat voiding dysfunction following antiincontinence surgery Curr Opin Obstet Gynecol 19(5): 490-495 (2007)
A-3.12.
D-2.113
Tamussino Karl; Hanzal Engelbert; Koelle Dieter; et al.
Transobturator tapes for stress urinary incontinence: Results of theAustrianregistryor(s): Austrian Urogynecol Working Grp
Am J Obstet Gynecol 197(6): 634.e1 (2007)
A-3.12.
D-2.114.
Rardin CR, Sung WM, Hampton BS,Clemons JL, Aguilar V, Sokol ER. Long-term follow-up of a transvaginal Burch urethropexy for stress urinary incontinence. Am J Obstet Gynecol 197 ( 6): 656.e1-656.e5 (2007)
A-3.12.
D-2.115
Barber Matthew D.; Kleeman Steven; Karram Mickey M.; et al. Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence
Obstet Gynecol 111(3):611-621 (2008)
A-3.12.
D-2.116
Stanford Edward J.; Paraiso Marie Fidela R. A comprehensive review of suburethral sling procedure complications
J Minimall Invasive Gynecol 15(2): 132-145 (2008)
A-3.12.
D-2.117
Kane Amy R.; Nager Charles W. Midurethral slings for stress urinary incontinence Clin Obstet Gynecol 51(1): 124-135 (2008)
A-3.12.
D-2.118
Murphy Miles; van Raalte Heather; Mercurio Eduardo; et al. Incontinence-related quality of life and sexual function following the tension-free vaginal tape versus the "inside-out" tension-free vaginal tape obturator. Int Urogynecol J 19(4):481-487 (2008)
A-3.12.
D-2.119
Ridgeway Beri M.; Arias Beatriz E.; Barber Matthew D.
Variation of the obturator foramen and pubic arch of the female bony pelvis Am J Obstet Gynecol 198(5):546.e1 (2008)
A-3.12.
D-2.120
Koch Yvonne Katherine P.; Zimmern Philippe. A critical overview of the evidence base for the contemporary surgical management of stress incontinence. Curr Opin Urology 18(4):370-376 (2008)
A-3.12.
D-2.121
Daneshgari Firouz; Kong Wesley; Swartz Mia. Complications of Mid Urethral Slings: Important Outcomes for Future Clinical Trials. J Urol 180(5):1890-1897 (2008)
A-3.12.
D-2.122
Murphy Miles. Use of Mesh and Materials in Pelvic Floor Surgery
Obstet Gynecol Clin North Am 36(3):615 (2009)
A-3.12.
D-2.123
Bader G.; Koskas M. Complications of mid urethral sling procedures for surgical treatment of female stress urinary incontinence. J de Gynecologie Obstetrique et Biol de la Reprod 38(8):S201-S211 (2009)
A-3.12.
D-2.124
Delorme E.; Hermieu J. -F. Guidelines for the surgical treatment of female urinary stress incontinence in women using the suburethral sling. Progres en Urologie 20(2): S132-S142 (2010)
A-3.12.
D-2.125
McNanley Anna R.; Buchsbaum Gunhilde M. TVT or TOT? When to avoid retropubic trocar passage
Int Urogynecol J 21(3):383-385 (2010)
A-3.12.
D-2.126
Cholhan Hilary J.; Hutchings Timothy B.; Rooney Kristin Dyspareunia associated with paraurethral banding in the transobturator sling. Am J Obstet Gynecol 202(5): 481.e1 (2010)
A-3.12.
D-2.127
Togami Joanna M.; Chow Denise; Winters J. Christian. To sling or not to sling at the time of anterior vaginal compartment repair. Curr Opın Urol 20 (4):269-274 (2010)
A-3.12.
D-2.128
Molden Stephanie; Patterson Danielle; Tarr Megan; et al. Risk factors leading to midurethral sling revision: a multicenter case-control study Int Urogynecol J 21(10): 1253-1259 (2010)
A-3.12.
D-2.129
Teo Roderick; Moran Paul; Mayne Christopher; et al. Randomized Trial of Tension-Free Vaginal Tape and Tension-Free Vaginal Tape-Obturator for Urodynamic Stress Incontinence in Women. J Urol 185(4):1350-1355 (2011)
A-3.12.
D-2.130
Yoost Timothy; Rames Ross; Lebed Brett; et al. Predicting for postoperative incontinence following sling incision
Int Urogynecol J 22(6):665-669 (2011)
A-3.12.
D-2.131
Kaeufl Stefanie D.; Kuhn Christina; Kunze Susanne; et al. Inhibin/activin-betaC subunit does not represent a prognostic parameter in human endometrial cancer
Arc Gynecol Obstet 284(1): 199-207 (2011)
A-3.13.
D-2.132
Ioannis Mylonas and Christian Schindlbeck. Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma. Arch Gynecol Obstet DOI: 10.1007/s00404-011-1914 (2011)
A-3.13.
D-2.133
Eva Martín, Mª Jesus Macías, Ana Belén Rodríguez Bújez, Beatriz Madrigal, Ignacio González Blanco, Mª Concepción Velasco. Hemangioma de ovario con luteinización estromal. Ginecología y obstetricia clínica, ISSN 1695-3827, 6 (2): 94-99 (2005)
A-4.1.
D-2.134.
Erdemoglu E, Kamaci M, Ozen S, et.al. Ovarian hemangioma with elevated CA125 and ascites mimicking ovarian cancer. Eur J Gynecol Oncol 27(2): 195-6 (2006).
A-4.1.
D-2.135.
Akbulut M, Bir F, Colakoglu N,et.al. Ovarian hemangıoma occurring synchronously with serous papillary carcinoma of the ovary and benign endometrial polyp. Annals Saudi Medicine 28(2):128-31 (2008).
A-4.1.
D-2.136.
Liapis A, Bakalianou K, Salakos N, et.al. Vascular tumors: rare neoplasms of the female genital tract. Eur J Gynecol Oncol 30(2): 220-2 (2009).
A-4.1.
D-2.137.
Comunoglu Cem; Atasoy Latife; Baykal Cem. Ovarian hemangioma occurring synchronously with contralateral mature cystic teratoma in an 81-year-old patient. Upsala J Med Sciences 115(4):297-299 (2010)
A-4.1.
D-2.138.
Yoshinaga M, Togami S, Tsujı T, et.al. Clinical outcome of metastasis uterine leiomyosarcoma and carcinosarcoma in a single institute. J Obstet Gynecol Res 33(6): 818-22 (2007).
A-4.2.
D-2.139.
Guandalini M, Steinke K, Francesconi A. Pulmonary metastasis from cervical adenocarcinoma regress to a ‘Hole’ lots of nothing. J Thoracic Oncol 4(4): 552-4 (2009).
A-4.2.
D-2.140
Sezen Ozan Seymen; Eraslan Guluzar; Coskuner Temel; et al. Endometrial Adenocarcinoma Metastasis to Nasal Skin
J Otolaryngology-Head & Neck Surgery 39(2): E8-E11 (2010)
A-4.3.
D-2.141.
Papadakis JC, Christodoulou N. Placenta percreta presenting in the first trimester: Review of the literature. Clin Exp Obstet Gynecol. 35 (2): 98-102 (2008).
A-4.4.
D-2.142.
Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of deciduas and extravillous trophoblast. Placenta 29 (7): 639-45 (2008).
A-4.4.
D-2.143.
Papadakis JC, Chiristodoulou N, Papageorgiou A, et.al. Placenta percreta presenting in the first trimester and resulting in severe consumption coagulopathy and hysterectomy: a cesa report. Clin Exp Obstet Gynecol. 35 (3):225-6 (2008).
A-4.4.
D-2.144
Comstock, Christine H. The antenatal diagnosis of placental attachment disorders. Current Opin Obstet Gynecol 23(2):117–122 (2011).
A-4.4.
D-2.145.
DuPont NC, Wang KH, Wadhwa PD, et.al. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 66 (2): 175-91 (2005).
A-5.1.
D-2.146
duPont NC; Wang KH; Wadhwa PD; et al. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: Determinations of a panel of nine cytokines in clinical sample culture supernatants J Reprol Immunol 66(2): 175-191 (2005)
A-5.1.
D-2.147
Juan Manuel Corpa. Ectopic pregnancy in animals and humans. Reproduction 131:631–640 (2006)
A-7.a.1.
D-2.148
Mustafa Ozat, Mine Kanat-Pektas and Tayfun Gungor. Pelvic hydatid disease mimicking ovarian malignancy, letter to the editors. Archives of Gynecology and Obstetrics
Volume 283, Number 4, 921-923 (2011)
A-7.a.2.
D-2.149
Balkanlı Kaplan P,Usta U,Inal HA, Tastekin E,Tokuc B. Neuromuscular morphometry of the uterine ligaments and vaginal wall in women with pelvic organ prolapse. Neurourology and Urodynamics 30(1): 126–132 (2011)
A-9.14
D-3. Science Citation Index (SCI), Social Science Citation Index (SSCI) ve Arts and Huminities Citation Index (AHCI) tarafından taranmayan hakemli uluslararası dergilerde verilen her bir atıf
D-3.1.
Sutton MY, Holland B, Denny TN, et al. Effect of pregnancy and human immunodeficiency virus infection on intracellular interleukin-2 production patterns. Clin Diagn Lab Immunol 11: 780-785 (2004).
A-3.4.
D-3.2.
Vitoratos N, Papadias C, Economou E, et.al. Elevated circulating IL-beta and TNF-alpha and unaltered IL-6 in first trimester pregnancies complicated by threatened abortion with an adverse outcome. Med Inflamation No: 30485 (2006).
A-3.4.
D-3.3.
Kiyokawa Y, Yoneyama Y. Relationship between adenosine and T-helper 1/T-helper 2 balance in hyperemesis gravidarum. Clin Chem Acta 370 (1-2): 137-42 (2006).
A-3.6.
D-3.4.
Carmichael SL, Shaw GM, Laurent C, et.al. Maternal Reproductive and demographic characteristics as risk factors for hypospadias. Pediatric Perinatal Epidem. 21 (3): 210-8 (2007).
A-3.6.
D-3.5.
Tkaczuk-Wlach J, Robak-Cholubek D, Sobstyl M, et. al. Hyperemesis Gravidarum. Przeglad Menopauzalny 6(5): 310-5 (2007).
A-3.6.
D-3.6.
A. G. Tamay and N. K. Kuşçu. Hyperemesis gravidarum: Current aspect. Journal of Obstetrics & GynaecologyJournal of Obstetrics & Gynaecology 31 (8): 708-712 (2011)
A-3.6.
D-3.7.
Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The molecular genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 26: 251-282 (2005).
A-3.7.
D-3.8.
Elkind-Hirsch, Karen E. Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome: Impact on Metabolic and Reproductive Abnormalities. Treatments in Endocrinology 5(3): 171-187 (2006)
A-3.7.
D-3.9.
Al-Hilli et. al. Procalcitonin as a Mediator of Chronic Inflammation in Obese Women with PCOS. Medical J Babylon 7(3-4) 505-510 (2010)
A-3.7.
D-3.10
MA Rezvanfar, A Ahmadi, HAS Saadi et. al. Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: Biochemical and pathological. Human Exp Toxicol 30(11): 10 (2011)
A-3.7.
D-3.11
Desai, Ashesh; Subramanian, Shyam. Polycystic Ovarian Syndrome and Obstructive Sleep Apnea. Curr Respir reviews 3(4): 278-281 (2007)
A-3.7.
D-3-12
A Mahde, M Shaker et.al. Study of Omentin1 and Other Adipokines and Hormones in PCOS Patients. OMJ. 24: 108-118 (2009)
A-3.7.
D-3.13
Li Weiping, Cheng Qingfeng, Ma Shikun, Liu Xiurong, Qin Hua, Bai Xiaoshu, Zhang Suhua and Li Qifu. Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Volume 30, Number 3, 283-287 (2006)
A-3.7.
D-3.14
Evanthia Diamanti-Kandarakis. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Reviews in Molecular Medicine, 10, e3 (2008).
A-3.7.
D-3.15
Elsamra M. Study of Interleukin-6 levels in obese patients with polycyctic ovarian syndrome. Alexandria Journal of Medicine, Vol 43, No 3 (2007)
A-3.7.
D-3.16
Gisel Ovies CarballoI; Emma Domínguez Alonso; Olga L. Verdeja Varela; Hugo Zamora Recinos. Frecuencia y características clínicas, hormonales y ultrasonográficas sugestivas de síndrome de ovarios poliquísticos en un grupo de mujeres con síndrome metabólico. Rev Cubana Endocrinol 19(1) (2008)
A-3.8.
D-3.17
Tarkun İ, Çetinarslan B, Cantürk Z, Türemen E. The Plasma Homocysteine Concentrations and Relationship with Insulin Resistance in Young Women with Polycystic Ovary Syndrome
Turkish J Endocrinol Metab, 1 : 23-28 (2005)
A-3.8.
D-3.18
Rode EC; Licea Puig ME. Diabetes autoinmune latente del adulto: ¿estamos diagnosticándola correctamente? Rev Cubana Endocrinol 19(1) (2008)
A-3.8.
D-3.19
Mardanian F, Moradi M. Comparison of Ovarian Morphology, Pattern of Menstrual Cycles, and Testosterone Level in Polycystic Ovary Syndrome Patients Regarding Body Mass Index Value. J Isfahan Med School 27(97): 411-17 (2009)
A-3.8.
D-3.20
Wang Yu-Xia; Xie Xing-Mei; Dai Ming; et al. Relationship between insulin resistance and adiponectin expression in a rat model of polycystic ovary syndrome Scientific Res Essays 5(13): 1632-1639 ( 2010)
A-3.8.
D-3.21
Kowalczuk D, Wawrzycka MB, Maj AH. Determination of nifedipine in serum of women in preterm labor by high-performance liquid chromatography with diode array detection. J Aoac Int 89 (1): 25-31 (2006).
A-3.9.
D-3.22
Matijevic R, Grgic O, Vasilj O. Ritodrine in oral maintenance of tocolysis after active preterm labor: Randomized controlled trial. Croation Med J 47 (1):25-31 (2006)
A-3.9.
D-3.23
Sayin NC, İnal HA, Varol FG. Pregnancies complicated by adnexal masses: a case series. Arc Gynecol Obstet 278 (6): 573-577 (2008)
A-3.9.
D-3.24
Torres-Cepeda D,Guerra-Velásquez M,Reyna-Villasmil E, Colmenares-Vega M,Delgado-Delgado O,Mejía-Montilla J,Reyna-Villasmil N. Tocólisis con clorhidrato de isoxuprina o nifedipina en la amenaza de parto pretérmino. Rev Obstet Ginecol Venez 70 (1) 2010
A-3.9.
D-3.25
Roos C,HCJ Scheepers L, WM Bloemenkamp K,Bolte A,Cornette J et .al.. Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial). BMC Pregnancy and Childbirth 9:42 (2009)
A-3.9.
D-3.26
Edwin Chandraharan, Sabaratnam Arulkumaran. Recent advances in management of preterm labor. J Obstet Gynecol India 55( 2): 118- 124 (2005)
A-3.9.
D-3.27
Bernard T. Haylen. Female voiding dysfunction: Prevalence and common associations. Current Urology Reports 10 (6): 421-427 (2009)
A-3.12.
D-3.28
Scott Serels. Thoughts on midurethral synthetic slings. Current Urology Reports 8 (5): 359-363 (2007)
A-3.12.
D-3.29
Moore, Robert D; Serels, Scott R; Davila, G Willy. Minimally invasive treatment for female stress urinary incontinence. Expert Review of Obstretrics and Gynecology 3, (2): 257-272 (2008)
A-3.12.
D-3.30
Muller M., Deval B. Existe-t-il des facteurs prédictifs d'échec ou de complications dans la chirurgie de l'incontinence urinaire d'effort par voie transobturatrice ? Gynécologie obstétrique & fertilité 35(4): 375-376 (2007)
A-3.12.
D-3.31
D. Riva, V. Saccà, A. Borsani, A. Mattucci. Persistent urinary retention after TVT: Case report and comments. Urogynaecologia Int J 20; 3 : 15-21 (2006)
A-3.12.
D-3.32
Briozzo DL, Nozar MF,Fiol V, Curbelo F. Eficacia y seguridad del sling transobturatriz de malla simple de polipropileno (TOT)
en el tratamiento de la incontinencia urinaria de esfuerzo femenina. Rev Med Urug 25: 141-148 (2009)
A-3.12.
D-3.33
G. Vignoli. Advanced diagnosic testing for female pelvic floor dysfunction. Urogynaecologia Int J 23; 1: 5-43 (2010)
A-3.12.
D-3.34
Arun Chawla. Transobturator tapes are preferable over transvaginal tapes for the management of female stress urinary incontinence: Against. Indian J Urol. 2009 Oct-Dec; 25(4): 554–557 (2009)
A-3.12.
D-3.35
Bolat F,Erkanlı S, Koçer NE. Ovarian Hemangioma: Report of Two Cases and Review of the Literature. Türk Patoloji Dergisi 26 (3): 264-266 (2010)
A-4.1.
D-3.36
Paweł Blecharz, Krzysztof Urbański, Anna Mucha-Małecka, Krzysztof Małecki and Marian Reinfuss, et al. Hematogenous metastases in patients with Stage I or II endometrial carcinoma. Strahlentherapie und Onkologie 187(11) (2011)
A-4.2.
D-3.37
Alberto Ibáñez Pinto, Estela Fernández Salgado, Elena Castro Ortiz, Ruth Baltar Arias, et.al. Hemorragia digestiva de origen incierto por un adenocarcinoma endometrial metastásico. Respuesta al tratamiento hormonal. Gastroenterol Hepatol. 30(9):530-3 (2007)
A-4.3.
D-3.38
Lee EH, Sohn JA,Lee JY,Choi EJ,Lee JA,Choi CW,Kim EK,Kim H,Jun JK, et.al. The Impact of Delayed Interval Delivery on Neonatal Mortality and Morbidity. J Korean Soc Neonatol. 18(1):111-116 (2011)
A-4.5.
D-3.39
Calışkan E, Cakıroğlu Y, Yücesoy İ. Sequental Cervical Cerklage in the same pregnancy: two multifetal pregnancy case reports. J Turk Soc Obstet Gynecol: 8( 3):200- 4 (2011)
A-4.5.
D-3.40
Sapmaz E, Bulut V,Çelik A,Akbulut H,İlhan N,Hanay F. Preeklamsi vakalarında neopterin ve TNF-alfa düzeylerinin incelenmesi. J Turk Soc Obstet Gynecol 3 (2): 83- 8 (2006)
A-5.1.
D-3.41
Safdarian L,Mossayebi E,Badehnoosh B. Medical management of ectopic pregnancy with high HCG levels: a case series. Middle East Fertility Society Journal,13( 1):57-58 (2008)
A-7.a.1.
D-3.42
Bolaji İ,Gupta S. Medical management of interstitial pregnancy with high serum beta-selective human chorionic gonadotrophin. Ultrasound 18: 60–67 (2010)
A-7.a.1.
D-3.43
Ersun BAŞ, Selma YAZICI, Ali Erdem BAKİ, Yalkın ÇALIK, Metin YAVUZ, Elif ÖNDER, Safinaz ATAOĞLU. The effect of number of births on bone mineral density in postmenopausal women. AJCI, Volume 4, Issue 2 (2010)
B-6.10.
F- Scientific Awards
F-6. Degree in science, art, culture and sports activities in national congresses and competitions
F-6.1. 1st place in the best poster category at the 2nd International and 5th National Menopause and Osteoporosis Congress (18-21 September 2002, Istanbul),
MA Yüce, P Balkanlı Kaplan, L Candan, F Guger, T Canda, T Help. ‘Prevention of cyclophosphamide-induced premature menopause by concomitant administration of GnRHa; A dose dependent relationship'
F-6.2. 3rd place in the best poster area at the 4th National Urogynecology Congress (21-24 October 2009, Istanbul),
Petek Balkanlı Kaplan, U Usta, HA Inal, T. Taştekin, B Tokuc.” ‘Neuromuscular morphometry of the uterine ligaments and vaginal wall in women with pelvic organ prolapse’
F-6.3. Poster winner in the best poster category at the 5th National Urogynecology Congress (19-21 October 2011, Istanbul),
H. Süt, Petek Balkanlı Kaplan 'The relationship between anterior vaginal wall prolapse and urinary symptoms'
